(VIANEWS) – JinkoSolar Holding Company Limited (JKS), Powell Industries (POWL), Vital Farms (VITL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. JinkoSolar Holding Company Limited (JKS)
53.3% sales growth and 10.71% return on equity
JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the design, development, production, and marketing of photovoltaic products. The company offers solar modules, silicon wafers, solar cells, recovered silicon materials, and silicon ingots. It also provides solar system integration services; and develops commercial solar power projects. The company sells its products to distributors, project developers, and system integrators; and utility, commercial, and residential customers under the JinkoSolar brand, as well as on an original equipment manufacturer basis. As of December 31, 2019, it had an integrated annual capacity of 15.0 gigawatt (GW) for silicon wafers, including 11.5 GW for mono wafers; 10.6 GW for solar cells; and 16.0 GW for solar modules. The company has operations in the People's Republic of China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and internationally. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People's Republic of China.
Earnings Per Share
As for profitability, JinkoSolar Holding Company Limited has a trailing twelve months EPS of $3.65.
PE Ratio
JinkoSolar Holding Company Limited has a trailing twelve months price to earnings ratio of 11.58. Meaning, the purchaser of the share is investing $11.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.71%.
Moving Average
JinkoSolar Holding Company Limited’s worth is under its 50-day moving average of $43.21 and way under its 200-day moving average of $47.93.
Yearly Top and Bottom Value
JinkoSolar Holding Company Limited’s stock is valued at $42.25 at 16:22 EST, way under its 52-week high of $69.14 and above its 52-week low of $38.43.
2. Powell Industries (POWL)
33.7% sales growth and 11.88% return on equity
Powell Industries, Inc., together with its subsidiaries, designs, develops, manufactures, sells, and services custom-engineered equipment and systems for the distribution, control, and monitoring of electrical energy. The company's principal products include integrated power control room substations, custom-engineered modules, electrical houses, medium-voltage circuit breakers, monitoring and control communications systems, motor control centers, and bus duct systems, as well as traditional and arc-resistant distribution switchgears and control gears. Its products have application in voltages ranging from 480 volts to 38,000 volts; and are used in oil and gas refining, onshore and offshore oil and gas production, petrochemical, liquid natural gas terminals, pipeline, terminal, mining and metals, light rail traction power, electric utility, pulp and paper, and other heavy industrial markets. It also provides value-added services, such as spare parts, field service inspection, installation, commissioning, modification and repair, retrofit and retrofill components for existing systems, and replacement circuit breakers for switchgear. The company has operations in the United States, Canada, the Middle East, Africa, Europe, Mexico, and Central and South America. Powell Industries, Inc. was founded in 1947 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Powell Industries has a trailing twelve months EPS of $2.29.
PE Ratio
Powell Industries has a trailing twelve months price to earnings ratio of 35.65. Meaning, the purchaser of the share is investing $35.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.88%.
Sales Growth
Powell Industries’s sales growth is 14.2% for the present quarter and 33.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 64.4% and 460%, respectively.
3. Vital Farms (VITL)
18.5% sales growth and 9.99% return on equity
Vital Farms, Inc. operates as an ethical food company in the United States. It produces five pasture-raised products sourced from animals raised on small family farms, including shell eggs, butter, hard-boiled eggs, ghee, and liquid whole eggs. The company's customers include natural retailers, mainstream retailers, and foodservice partners. Vital Farms, Inc. was founded in 2007 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, Vital Farms has a trailing twelve months EPS of $0.23.
PE Ratio
Vital Farms has a trailing twelve months price to earnings ratio of 50.02. Meaning, the purchaser of the share is investing $50.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.99%.
Yearly Top and Bottom Value
Vital Farms’s stock is valued at $11.50 at 16:22 EST, way under its 52-week high of $18.18 and way above its 52-week low of $10.23.
Moving Average
Vital Farms’s value is below its 50-day moving average of $12.20 and way under its 200-day moving average of $14.27.
4. CIRCOR International (CIR)
12.7% sales growth and 29.8% return on equity
CIRCOR International, Inc. designs, manufactures, and distributes flow and motion control products. The company has a product portfolio of brands serving its customers' demanding applications. It operates through two segments, Aerospace & Defense and Industrial. The Aerospace & Defense segment manufactures and markets control valves, pumps, regulators, fluid controls, actuation systems, pneumatic valves and controls, electro-mechanical controls, motors, and other flow control products and systems. Its products and services are used in the military and defense, commercial aerospace, business and general aviation, and general industrial markets, as well as serves aircraft manufacturers and tier 1 suppliers. This segment offers its products under the CIRCOR Aerospace, Aerodyne Controls, CIRCOR Bodet, CIRCOR Industria, CIRCOR Motors, Hale Hamilton, Leslie Controls, Portland Valve, and Warren Pumps brands. The Industrial segment provides 3 and 2 screw pumps, progressing cavity pumps, specialty centrifugal pumps, and gear metering pumps; automatic recirculation valves; general service control valves; and pipeline pigs and closures for the end-users and original equipment manufacturers, as well as engineering, procurement, and construction companies. This segment offers its products under the Allweiler, Houttuin, IMO Pump, IMO AB, Leslie Controls, RG Lawrence, RTK, Schroedahl, Tushaco, and Zenith brands. The company has operations in Europe, the Middle East, Africa, North America, and internationally. The company markets its solutions directly and through various sales partners to approximately 14,000 customers in approximately 100 countries. CIRCOR International, Inc. was incorporated in 1999 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, CIRCOR International has a trailing twelve months EPS of $1.98.
PE Ratio
CIRCOR International has a trailing twelve months price to earnings ratio of 28.08. Meaning, the purchaser of the share is investing $28.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.8%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CIRCOR International’s EBITDA is 36.58.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 804.36M for the twelve trailing months.
5. Amazon (AMZN)
11.5% sales growth and 8.71% return on equity
Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions through online and physical stores in North America and internationally. It operates through three segments: North America, International, and Amazon Web Services (AWS). The company's products offered through its stores include merchandise and content purchased for resale; and products offered by third-party sellers. It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Rings, Blink, eero, and Echo; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as fulfillment, advertising, and digital content subscriptions. Additionally, the company offers Amazon Prime, a membership program. It serves consumers, sellers, developers, enterprises, content creators, and advertisers. The company was incorporated in 1994 and is headquartered in Seattle, Washington.
Earnings Per Share
As for profitability, Amazon has a trailing twelve months EPS of $0.42.
PE Ratio
Amazon has a trailing twelve months price to earnings ratio of 330.02. Meaning, the purchaser of the share is investing $330.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.71%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.8%, now sitting on 538.05B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amazon’s EBITDA is 2.79.
Yearly Top and Bottom Value
Amazon’s stock is valued at $138.61 at 16:22 EST, under its 52-week high of $146.57 and way above its 52-week low of $81.43.
Sales Growth
Amazon’s sales growth is 11.3% for the current quarter and 11.5% for the next.
Previous days news about Amazon(AMZN)
- According to FXStreet on Sunday, 13 August, "Companies Analyzed: Apple (AAPL), Tesla (TSLA), Amazon (AMZN), Nvidia (NVDA), Microsoft (MSFT), Meta Platforms, Netflix (NFLX), Alphabet (GOOGL)", "00:00 NASDAQ 100 4.23 Apple (AAPL) 10:52 Amazon (AMZN) 12:36 NVIDIA (NVDA) 17:05 Meta Platforms (META) 18:46 Netflix (NFLX) 20:53 Alphabet (GOOGL) 23:55 Microsoft MSFT 25:55 Tesla (TSLA)"
- Zacks investment ideas feature highlights: Amazon, sherwin williams and caterpillar. According to Zacks on Monday, 14 August, "If Amazon can trade above the $139.50 level, it should initiate a breakout and draw in a rush of buyers sending the stock higher. ", "During the last quarterly earnings report Amazon surprised to the upside by 43%, showing just how effective its restructuring has been this last year. "
6. Royalty Pharma (RPRX)
11.5% sales growth and 4.66% return on equity
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $0.74.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 40.99. Meaning, the purchaser of the share is investing $40.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.66%.
Moving Average
Royalty Pharma’s value is below its 50-day moving average of $31.29 and way below its 200-day moving average of $36.31.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Royalty Pharma’s EBITDA is 7.58.
Volume
Today’s last reported volume for Royalty Pharma is 728138 which is 69.93% below its average volume of 2421520.
